Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Perrigo Company plc    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/13/2020 01/14/2020 01/15/2020 01/16/2020 01/17/2020 Date
50.54(c) 56.91(c) 58.52(c) 59.51(c) 59.02(c) Last
904 369 3 153 512 2 775 938 1 263 166 1 079 979 Volume
+1.67% +12.60% +2.83% +1.69% -0.82% Change
More quotes
Financials (USD)
Sales 2019 4 801 M
EBIT 2019 806 M
Net income 2019 269 M
Debt 2019 2 882 M
Yield 2019 1,37%
Sales 2020 4 980 M
EBIT 2020 871 M
Net income 2020 401 M
Debt 2020 2 482 M
Yield 2020 1,37%
P/E ratio 2019 29,9x
P/E ratio 2020 17,4x
EV / Sales2019 2,27x
EV / Sales2020 2,11x
Capitalization 8 033 M
More Financials
Company
Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences.... 
Sector
Pharmaceuticals
Calendar
03/06Earnings Release
More about the company
Surperformance© ratings of Perrigo Company plc
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY PLC
01/14PERRIGO CO PLC : Results of Operations and Financial Condition, Financial Statem..
AQ
01/07PERRIGO : Advances Consumer Self-Care Growth Strategy with Ranir Subsidiary Acqu..
AQ
2019PERRIGO : Donates a Total of $75,000 to Wings of Hope Hospice and Wings Home
AQ
2019PERRIGO : Announces Closing of Prevacid24HR Acquisition, Advancing Consumer Self..
AQ
2019PERRIGO COMPANY PLC : Ex-dividend day for
FA
2019PERRIGO : Donates Building Appraised at $320,000 to Safe Harbor to Protect Child..
AQ
2019PERRIGO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
2019PERRIGO CO PLC : Results of Operations and Financial Condition, Financial Statem..
AQ
2019PERRIGO : 3Q Earnings Snapshot
AQ
2019PERRIGO : Ranitidine - MHRA drug alerts issued as Perrigo recalls prescription o..
AQ
2019PERRIGO : Scientists Aim to Beat World Record While Inspiring Kids to Explore 'S..
AQ
2019PERRIGO : Voluntarily Halts Distribution of Ranitidine-Based Product
AQ
2019PERRIGO : Charitable Foundation Donates More Than $20,000 to Hurricane Dorian Re..
AQ
2019PERRIGO : Advances Consumer Self-Care Growth Strategy with Acquisition of Prevac..
AQ
2019PERRIGO : Buys Prevacid U.S. OTC Rights From GlaxoSmithKline
DJ
More news
News in other languages on PERRIGO COMPANY PLC
2019PERRIGO COMPANY PLC : Ex-dividend day for
2019GLAXOSMITHKLINE : Perrigo achète les droits du Prevacid
2019PERRIGO COMPANY PLC : Ex-dividend day for
2019WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
2019Le bénéfice de Johnson & Johnson bondit de 41,8% au deuxième trimestre
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Sector news : Pharmaceuticals - NEC
07:44aMyriad Submits sPMA for BRACAnalysis CDx Test
DJ
07:29aAstraZeneca, Merck Get FDA Priority Review for Lynparza in Form of Prostate C..
DJ
01/20JPMorgan says 'oui' to Paris expansion post-Brexit
RE
01/20ALLERGAN : Form 8.3 - Allergan Plc
DJ
01/20ABBVIE : Form 8.3 - Abbvie Inc
DJ
More sector news : Pharmaceuticals - NEC
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 54,00  $
Last Close Price 59,02  $
Spread / Highest target 1,66%
Spread / Average Target -8,51%
Spread / Lowest Target -18,7%
EPS Revisions
Managers
NameTitle
Murray S. Kessler President, Chief Executive Officer & Director
Rolf Allan Classon Chairman
Ronald Janish Executive VP-Global Operations and Supply Chain
Raymond P. Silcock Chief Financial & Accounting Officer
Thomas Farrington Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY PLC14.25%8 033
JOHNSON & JOHNSON2.26%392 596
ROCHE HOLDING AG4.44%289 068
MERCK AND COMPANY0.02%231 608
PFIZER3.39%224 187
NOVARTIS0.96%216 654